Source: International Congress 2016 – Cystic fibrosis: various aspects
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cedric Van Holsbeke (Kontich, Belgium), Aukje Bos, Cedric Van Holsbeke, Jan De Backer, Hettie Janssens, Wim Vos, Harm Tiddens. Effect of nebulizer system on tobramycin concentration using functional respiratory imaging (FRI). Eur Respir J 2016; 48: Suppl. 60, 1256

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Functional respiratory imaging (FRI) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using novel Co-Suspension Delivery Technology (GFF MDI) in COPD Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017 Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Specific cystic fibrosis (CF) abnormalities studied by multi-volume CT and proton MRI (1H-MRI) Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Z7200 versus Symbicort® Turbohaler®: A pharmacodynamic evaluation of the acute effects using functional respiratory imaging (FRI) Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Validation of commercial devices for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in school-aged children Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects Year: 2015 Validation of nitrogen washout (N2-WO) for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in preschoolers Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016 Comparison of CF and non CF FRC and LCI values measured with Exhalyzer D and InnocorTM devices Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015 Comparison of functional residual capacity (FRC) from two multiple breath washout (MBW) systems and body plethysmography Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016 Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF) Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Year: 2015 Oxygen-enhanced MR (OE-MR): Correlation to CT Brody score in cystic fibrosis patients Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Ventilation inhomogeneity (VI) and spirometry in response to intravenous antibiotics (IVab) in cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Visualising regional ventilation heterogeneity by linking multiple breath washout to 3He MRI imaging Source: International Congress 2014 – Functional imaging Year: 2014 Structure-function relationships in the lungs of cystic fibrosis (CF) patients using multi-volume high-resolution CT (HRCT) and proton MRI (1H-MRI) Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Edry™ an innovative dry powder technology evaluated via functional respiratory imaging (FRI) Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Lung deposition of extrafine vs non-extrafine triple therapies in patients with COPD using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019 Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Rapid and portable MBW measurements for clinical application of LCI in routine clinics Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 Quantitative lung T1 mapping and oxygen enhanced MRI in IPF Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014